Section of Trauma, Surgical Critical Care, and Surgical Emergencies, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Surg Infect (Larchmt). 2012 Aug;13(4):194-202. doi: 10.1089/sur.2012.121. Epub 2012 Aug 22.
Multi-drug-resistant organisms (MDRO) complicate care increasingly on the general ward and in the emergency department, operating room, and intensive care unit (ICU). Whereas barrier precautions are important in limiting transmission of MDRO between patients, few tactics have been defined that reduce the genesis of MDRO.
Review of pertinent English-language literature.
Antibiotic heterogeneity practices, as part of an overall antimicrobial drug stewardship program, offer one readily deployable means to reduce selection pressure for MDRO development in the ICU. The data underpinning this approach and data derived from its use indicate that, especially in surgical ICUs, heterogeneity of antibiotic prescribing can preserve or restore microbial ecology, reduce the prevalence of MDRO and the incidence of infections caused thereby, and facilitate the implementation and effectiveness of other antibiotic-sparing tactics, such as de-escalation.
Heterogeneity of antibiotic prescribing is effective in preventing the dissemination of MDRO pathogens.
多药耐药菌(MDRO)在普通病房以及急诊科、手术室和重症监护病房(ICU)中越来越多地给治疗带来复杂性。虽然屏障预防措施对于限制 MDRO 在患者之间的传播很重要,但很少有策略可以减少 MDRO 的产生。
回顾相关的英文文献。
抗生素异质性实践作为整体抗菌药物管理计划的一部分,为减少 ICU 中 MDRO 发展的选择压力提供了一种易于部署的手段。该方法的基础数据以及由此产生的数据表明,特别是在外科 ICU 中,抗生素使用的异质性可以维持或恢复微生物生态,降低 MDRO 的流行率和由此引起的感染发生率,并促进其他节省抗生素策略的实施和有效性,如降级治疗。
抗生素使用的异质性可有效防止 MDRO 病原体的传播。